In this episode of ASTCT Talks, we sit down with Parameswaran Hari, MD, MCRP to discuss the role of minimal residual disease in multiple myeloma. Hari, the Armand J. Quick/William F. Stapp Professor of Hematology and the Chief of the Division of Hematology/Oncology at the Medical College of Wisconsin, said advances in MRD testing signals improvement in progression-free survival in multiple myeloma. While this is good news for clinicians, there’s still a ways to go to ensure MRD testing is being understood correctly.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
TNB Tech Minute: FTC Orders Instacart to Pay $60 Million Over Deceptive Practices
18 Dec 2025
WSJ Tech News Briefing
Hidden Gem Stocks We Love at the End of the Year
18 Dec 2025
Motley Fool Money
Google Undercuts the Field, OpenAI Builds an App OS, and China Accelerates
18 Dec 2025
The Daily AI Show
Lucy Liu
18 Dec 2025
Fresh Air
#2428 - Michael P. Masters
18 Dec 2025
The Joe Rogan Experience